Trial · NCT03246958
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Best Overall Response Rate | Differentiated Thyroid Cancer (Primary Cohort) | 9.4 | 95% Confidence Interval 2.8 to 28.5 | percentage of participants | |
| Best Overall Response Rate | Medullary Thyroid Cancer (Exploratory Cohort) | 0 | 95% Confidence Interval 0 to 41 | percentage of participants | |
| Best Overall Response Rate | Anaplastic Thyroid Cancer (Exploratory Cohort) | 30 | 95% Confidence Interval 6.7 to 65.2 | percentage of participants | |
| Median Progression Free Survival | Differentiated Thyroid Cancer (Primary Cohort) | 7.11 | 95% Confidence Interval 2.07 to 17.02 | Months | |
| Median Progression Free Survival | Medullary Thyroid Cancer (Exploratory Cohort) | 2.14 | 95% Confidence Interval 0.92 to 3.98 | Months | |
| Median Progression Free Survival | Anaplastic Thyroid Cancer (Exploratory Cohort) | 4.29 | 95% Confidence Interval 0.46 to NA | Months | |
| Overall Survival at 2 Years (OS2) | Differentiated Thyroid Cancer (Primary Cohort) | 77.2 | 95% Confidence Interval 58.1 to 88.5 | Percent Probability | |
| Overall Survival at 2 Years (OS2) | Medullary Thyroid Cancer (Exploratory Cohort) | 85.7 | 95% Confidence Interval 33.4 to 97.9 | Percent Probability | |
| Overall Survival at 2 Years (OS2) | Anaplastic Thyroid Cancer (Exploratory Cohort) | 55.6 | 95% Confidence Interval 20.4 to 80.5 | Percent Probability | |
| Treatment-Related Adverse Events Rate | Differentiated Thyroid Cancer (Primary Cohort) | 0.81 | 95% Confidence Interval 0.64 to 0.93 | proportion of participants | |
| Treatment-Related Adverse Events Rate | Medullary Thyroid Cancer (Exploratory Cohort) | 1 | 95% Confidence Interval 0.59 to 1 | proportion of participants | |
| Treatment-Related Adverse Events Rate | Anaplastic Thyroid Cancer (Exploratory Cohort) | 0.80 | 95% Confidence Interval 0.44 to 0.97 | proportion of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03246958/results